Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Euphrasia D3 eye drops
- Development stage
- Unknown
- Lead developer
- Weleda
- Administration
- Ophthalmic
01
Overview
Euphrasia D3 eye drops are a homeopathic/herbal ophthalmic preparation manufactured by Weleda, containing extracts of the *Euphrasia officinalis* (Eyebright) plant. The drug is currently being evaluated in a Phase 2 clinical trial led by Larkin Community Hospital to assess its efficacy in controlling postoperative intraocular inflammation following Peripheral Laser Iridotomy (PLI) for narrow-angle glaucoma. The study aims to determine if this herbal remedy is non-inferior to standard corticosteroid therapy (prednisolone acetate) in reducing inflammation and preventing complications such as pressure spikes. While Euphrasia has been used traditionally for centuries to treat conjunctivitis and ocular irritation, this research represents an effort to provide standardized clinical evidence for its use in a surgical recovery context.
- Brand names
- Weleda Euphrasia D3
- Other names
- EuphrasiaEyebrightEuphrasia officinalis
Beyond the preview
Go deeper on Euphrasia D3 eye drops.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Euphrasia D3 eye drops.